Dr. Surya K Nallari, M.D. Internal Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 417 N Halleck St, Demotte, IN 46310 Phone: 219-987-6010 Fax: 219-987-4546 |
News Archive
MAP Pharmaceuticals, Inc. today announced new data from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX orally inhaled migraine therapy showing low recurrence rates with LEVADEX. Eight additional analyses from the LEVADEX program also will be presented during the 2010 European Headache and Migraine Trust International Congress (EHMTIC) in Nice, France.
A study published today in JAMA Internal Medicine shows that wearing two face coverings can nearly double the effectiveness of filtering out SARS-CoV-2-sized particles, preventing them from reaching the wearer's nose and mouth and causing COVID-19.
Bristol-Myers Squibb Company (NYSE:BMY) announced today that the United States District Court for the Southern District of New York has granted preliminary approval of settlement of Sampson v. Robinson, et al., Case No. 1:07-CV-06890 (on appeal: Case No. 08-5475), a shareholder action pursued derivatively on behalf of Bristol-Myers Squibb. The action concerned allegations relating to the efforts to settle the Plavix patent litigation in 2006. The proposed settlement is subject to final Court approval. The Court has set a final approval hearing for December 8, 2009 at 2 p.m. in the courtroom of the Honorable Paul A. Crotty, United States District Judge.
More than $9 million in federal grants will help fund researchers in the Ohio State University Davis Heart and Lung Research Institute and their collaborators across the university campus to investigate new causes and treatments for cardiovascular disease.
Participating in spiritual practices during childhood and adolescence may be a protective factor for a range of health and well-being outcomes in early adulthood, according to a new study from Harvard T.H. Chan School of Public Health.
› Verified 7 days ago